Major indexing service sounds alarm on self-citations by nearly 50 journals

More than 70% of the citations in one journal were to other papers in that journal. Another published a single paper that cited nearly 200 other articles in the journal. Now, Clarivate, the company behind the Impact Factor, is taking steps to fight such behavior, suppressing 33 journals from their indexing service and subjecting 15 … Continue reading Major indexing service sounds alarm on self-citations by nearly 50 journals

Journal calls 2012 paper “deeply offensive to particular minorities”

An Elsevier journal plans to issue a retraction notice this week about a widely criticized 2012 paper claiming to find links between skin color, aggression, and sexuality. Earlier this month, we reported that the journal, Personality and Individual Differences (PAID), would retract the study “Do pigmentation and the melanocortin system modulate aggression and sexuality in … Continue reading Journal calls 2012 paper “deeply offensive to particular minorities”

Journal temporarily withdraws COVID-19 “labor cage” study

A study whose title suggested an “effective” way to give birth during the coronavirus pandemic has been temporarily retracted because the publisher says the word “effective” was included in the title by accident. The method (pictured above) involved an enclosed, transparent chamber walling off the mother’s upper half from the rest of the world. It … Continue reading Journal temporarily withdraws COVID-19 “labor cage” study

Weekend reads: When peer review fails; gender imbalances in citations; COVID-19 science under scrutiny

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: A paper that took a journal three days to accept … Continue reading Weekend reads: When peer review fails; gender imbalances in citations; COVID-19 science under scrutiny

Meet Bo Liu, international man or woman of scientific mystery

An Elsevier journal is wearing an omelet on its face after accepting a paper by a group of authors who have completely disavowed the work.  Oh, and no one seems to know who one of the authors is, which makes the second time inside of a month that we’ve reported on a case like this. … Continue reading Meet Bo Liu, international man or woman of scientific mystery

Race to be first to report first case of COVID-19 death during pregnancy leads to a retraction

A group of researchers in Iran has retracted their case report on what they claimed was the first known case of a pregnant woman who died of Covid-19.  The reason: According to the corresponding author, another group of researchers in Iran, who had first seen the patient at their hospital, had beaten them to the … Continue reading Race to be first to report first case of COVID-19 death during pregnancy leads to a retraction

‘Negligence’ — a lot of it — leads to a retraction

Some words do more work in sentences than others. Take the example of the word  “negligence,” which in the case of the following retraction notice is a veritable beast of burden. The 2019 article, “Conservative management of subglottic stenosis with home based tracheostomy care: A retrospective review of 28 patients,” appeared in the International Journal … Continue reading ‘Negligence’ — a lot of it — leads to a retraction

What it takes to correct the record: Autopsy of a COVID-19 corrigendum

We’ve been keeping track of retracted coronavirus papers, but what about corrections? Here’s a guest post from Richard Jones of Cardiff University about a paper that earned widespread media coverage but turned out to be wrong. According to our best knowledge, this is the first report on COVID-19 infection and death among medical personnel in … Continue reading What it takes to correct the record: Autopsy of a COVID-19 corrigendum

French hydroxychloroquine-COVID-19 study withdrawn

The authors of a preprint on use of hydroxychloroquine — the controversial drug heavily promoted by, and now apparently taken by, President Trump, at least for a few more days — along with azithromycin for COVID-19 have withdrawn the paper. The preprint, “Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 … Continue reading French hydroxychloroquine-COVID-19 study withdrawn

Covid-19 and sex? Rapid-fire acceptance leads to hasty withdrawal of paper

The Journal of the American Academy of Dermatology has taken down a letter on whether people should abstain from sex during the coronavirus pandemic, but the editor says the article is not being retracted.  Meanwhile, researchers in France have retracted a paper in which they’d claimed to have found  replication of the virus that causes … Continue reading Covid-19 and sex? Rapid-fire acceptance leads to hasty withdrawal of paper